Forte Biosciences (FBRX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts FBRX Hot Sheet
Join SI Premium – FREE
Forte Biosciences (NASDAQ: FBRX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
- Morgan Stanley Downgrades Melco Resorts (MLCO) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
